V. Molina

801 total citations
25 papers, 629 citations indexed

About

V. Molina is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Nutrition and Dietetics. According to data from OpenAlex, V. Molina has authored 25 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Nutrition and Dietetics. Recurrent topics in V. Molina's work include Natural Products and Biological Research (20 papers), Fatty Acid Research and Health (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). V. Molina is often cited by papers focused on Natural Products and Biological Research (20 papers), Fatty Acid Research and Health (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). V. Molina collaborates with scholars based in Cuba, Italy and Lebanon. V. Molina's co-authors include M.L. Arruzazabala, Daisy Carbajal, Rosa Más, S. Valdés, M Noa, R Más, Lara P. Fernández, Roberto Menéndez, Eduardo Rodríguez and Soaira Mendoza and has published in prestigious journals such as Atherosclerosis, Pharmacological Research and Pflügers Archiv - European Journal of Physiology.

In The Last Decade

V. Molina

23 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Molina Cuba 17 407 133 94 83 79 25 629
Vivián Molina Cuba 17 412 1.0× 115 0.9× 75 0.8× 58 0.7× 105 1.3× 47 693
M.L. Arruzazabala Cuba 20 694 1.7× 242 1.8× 103 1.1× 83 1.0× 106 1.3× 32 977
José Illnait Cuba 18 850 2.1× 191 1.4× 68 0.7× 17 0.2× 93 1.2× 44 980
Eda Dokumacıoğlu Türkiye 12 44 0.1× 75 0.6× 104 1.1× 15 0.2× 36 0.5× 36 499
Aki Naemura Japan 12 62 0.2× 124 0.9× 41 0.4× 5 0.1× 58 0.7× 19 464
Farah Farokhi Iran 13 33 0.1× 85 0.6× 61 0.6× 11 0.1× 38 0.5× 42 470
Lilia Fernández Cuba 20 792 1.9× 184 1.4× 44 0.5× 2 0.0× 79 1.0× 36 931
Woo‐Young Jeon South Korea 13 26 0.1× 67 0.5× 50 0.5× 41 0.5× 59 0.7× 42 450
Kavitha Penugonda United States 5 25 0.1× 141 1.1× 66 0.7× 16 0.2× 42 0.5× 7 462
Ahsen Yılmaz Türkiye 10 64 0.2× 28 0.2× 20 0.2× 20 0.2× 23 0.3× 30 345

Countries citing papers authored by V. Molina

Since Specialization
Citations

This map shows the geographic impact of V. Molina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Molina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Molina more than expected).

Fields of papers citing papers by V. Molina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Molina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Molina. The network helps show where V. Molina may publish in the future.

Co-authorship network of co-authors of V. Molina

This figure shows the co-authorship network connecting the top 25 collaborators of V. Molina. A scholar is included among the top collaborators of V. Molina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Molina. V. Molina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Molina, V., et al.. (2024). Balancing act on clopidogrel: exercise induced hematoma leading to neuropathy in a stroke survivor. The American Journal of the Medical Sciences. 367. S105–S106.
3.
Molina, V., et al.. (2013). Therapeutic Effects of Policosanol and Atorvastatin against Global Brain Ischaemia-Reperfusion Injury in Gerbils.. PubMed. 75(6). 635–41. 9 indexed citations
4.
Arruzazabala, M.L., et al.. (2006). Effect of D-004, a Lipid Extract from the Cuban Royal Palm Fruit, on Atypical Prostate Hyperplasia Induced by Phenylephrine in Rats. Drugs in R&D. 7(4). 233–241. 43 indexed citations
5.
6.
Carbajal, Daisy, V. Molina, Rosa Más, & M.L. Arruzazabala. (2005). Therapeutic effect of D-004, a lipid extract from Roystonea regia fruits, on prostate hyperplasia induced in rats.. PubMed. 31(5-6). 193–7. 35 indexed citations
7.
Noa, M, M.L. Arruzazabala, Daisy Carbajal, R Más, & V. Molina. (2005). Effect of D-004, a lipid extract from Cuban royal palm fruit, on histological changes of prostate hyperplasia induced with testosterone in rats.. PubMed. 27(4). 203–11. 27 indexed citations
8.
Arruzazabala, M.L., Rosa Más, V. Molina, et al.. (2004). Effects of d-003, a new substance purified from sugar cane wax, on platelet aggregation and plasma levels of arachidonic acid metabolites in healthy volunteers.. PubMed. 24(2-3). 55–63. 5 indexed citations
9.
Arruzazabala, M.L., et al.. (2004). Preventive effects of D-004, a lipid extract from Cuban royal palm (Roystonea regia) fruits, on testosterone-induced prostate hyperplasia in intact and castrated rodents.. PubMed. 30(5-6). 227–33. 36 indexed citations
10.
Molina, V., M.L. Arruzazabala, Daisy Carbajal, & Rosa Más. (2003). Synergistic effect of D-003 and aspirin on experimental thrombosis models. Prostaglandins Leukotrienes and Essential Fatty Acids. 68(5). 305–310. 11 indexed citations
11.
Carbajal, Daisy, M.L. Arruzazabala, M Noa, et al.. (2003). Protective effect of D-003 on experimental spinal cord ischemia in rabbits. Prostaglandins Leukotrienes and Essential Fatty Acids. 70(1). 1–6. 8 indexed citations
12.
Molina, V., M.L. Arruzazabala, Daisy Carbajal, & Rosa Más. (2002). D-003, a potential antithrombotic compound isolated from sugar cane wax with effects on arachidonic acid metabolites. Prostaglandins Leukotrienes and Essential Fatty Acids. 67(1). 19–24. 22 indexed citations
13.
Molina, V., M.L. Arruzazabala, Daisy Carbajal, Rosa Más, & S. Valdés. (2000). Antiplatelet and Antithrombotic Effect of D-003. Pharmacological Research. 42(2). 137–143. 44 indexed citations
14.
Carbajal, Daisy, V. Molina, M Noa, et al.. (2000). Effect of D-002 on gastric mucus composition in ethanol-induced ulcer. Pharmacological Research. 42(4). 329–332. 30 indexed citations
15.
Arruzazabala, M.L., M Noa, Roberto Menéndez, et al.. (2000). Protective effect of policosanol on atherosclerotic lesions in rabbits with exogenous hypercholesterolemia. Brazilian Journal of Medical and Biological Research. 33(7). 835–840. 34 indexed citations
16.
Carbajal, Daisy, et al.. (1998). Anti-inflammatory activity of D-002: an active product isolated from beeswax. Prostaglandins Leukotrienes and Essential Fatty Acids. 59(4). 235–238. 45 indexed citations
17.
Valdés, S., M.L. Arruzazabala, Lara P. Fernández, et al.. (1996). Effect of policosanol on platelet aggregation in healthy volunteers.. PubMed. 16(2-3). 67–72. 30 indexed citations
18.
Carbajal, Daisy, M.L. Arruzazabala, Rosa Más, V. Molina, & S. Valdés. (1994). Effect of policosanol on experimental thrombosis models. Prostaglandins Leukotrienes and Essential Fatty Acids. 50(5). 249–251. 18 indexed citations
19.
Arruzazabala, M.L., et al.. (1994). Cholesterol-lowering effects of policosanol in rabbits.. PubMed. 27(3-4). 205–8. 84 indexed citations
20.
Arruzazabala, M.L., V. Molina, Daisy Carbajal, S. Valdés, & Rosa Más. (1993). Effect of policosanol on cerebral ischemia in Mongolian gerbils: Role of prostacyclin and thromboxane A2. Prostaglandins Leukotrienes and Essential Fatty Acids. 49(3). 695–697. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026